Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10746690 | 1.00 | ADRA2C (0.56) | ADRA2CKMT2AMEN1PABPC1MAPK1 | |
| SCHEMBL10746679 | 1.00 | ADRA2C (0.56) | ADRA2CKMT2AMEN1PABPC1MAPK1 | |
| SCHEMBL11371658 | 0.81 | GAA (0.40) | ADRA2CKMT2AMEN1PABPC1MAPK1 | |
| SCHEMBL21203108 | 0.80 | — | — | |
| SCHEMBL11319077 | 0.79 | GAA (0.39) | ADRA2CKMT2AMAPK1GAATP53 | |
| SCHEMBL1862874 | 0.77 | L3MBTL1 (0.43) | ADRA2CKMT2AMAPK1GAATP53 | |
| SCHEMBL11381775 | 0.77 | GAA (0.47) | ADRA2CKMT2AMAPK1GAATP53 | |
| SCHEMBL14600741 | 0.73 | KMT2A (0.54) | ADRA2CKMT2AMEN1PABPC1MAPK1 | |
| Mebicar SCHEMBL1465373 | 0.72 | ADRA2C (1.00) | ADRA2CKMT2AMEN1PABPC1MAPK1 | |
| Mebicar SCHEMBL15685069 | 0.72 | ADRA2C (1.00) | ADRA2CKMT2AMEN1PABPC1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680201-A1 | COMPOSITIONS AND USES THEREOF FOR STABILIZATION OF BLOOD SAMPLE COMPONENTS | Streck LLC (US) | 2026-01-21 | — | — | EP | claimed |
| WO-2024192232-A9 | COMPOSITIONS AND USES THEREOF FOR STABILIZATION OF BLOOD SAMPLE COMPONENTS | STRECK LLC (US) | 2025-02-06 | — | — | WO | claimed |
| CN-119121656-A | Machining process for machine washable high-color-fastness silk fabric | 达利(中国)有限公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2024192232-A1 | COMPOSITIONS AND USES THEREOF FOR STABILIZATION OF BLOOD SAMPLE COMPONENTS | STRECK LLC (US) | 2024-09-19 | — | — | WO | claimed |
| US-11400042-B2 | Process for treating keratin fibres, comprising the application of a composition comprising urea or a derivative thereof, a polyol and an amino silicone | L'OREAL (FR) | 2022-08-02 | — | — | US | claimed |
| US-11298305-B2 | Compositions and methods for improving the appearance of the hair | L'OREAL (FR) | 2022-04-12 | — | — | US | claimed |
| EP-3261501-B1 | SOFT, STRONG AND BULKY TISSUE | KIMBERLY CLARK CO (US) | 2021-09-08 | — | — | EP | claimed |
| US-11035081-B2 | Resilient high bulk tissue products | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2021-06-15 | — | — | US | claimed |
| EP-2988830-B1 | COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF | OREAL (FR) | 2021-03-17 | — | — | EP | claimed |
| US-20210054572-A1 | LAYERED FIBROUS STRUCTURES COMPRISING CROSS-LINKED FIBERS | KIMBERLY CLARK CO (US) | 2021-02-25 | — | — | US | claimed |
| EP-0330979-B1 | AQUEOUS COMPOSITION FOR THE TREATMENT OF TEXTILES AND METHOD OF MAKING TEXTILE MATERIALS CREASE-PROOF | Pfersee Chemie GmbH (DE) | 1993-09-29 | — | — | EP | claimed |
| US-5225047-A | Less fiber breakage | WEYERHAEUSER COMPANY (US) | 1993-07-06 | — | — | US | claimed |
| US-5021263-A | Whole or partial etherified 1,3-dialkyl-4,5-dihydroxy-imidazolidinone; shrink resistace | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | claimed |
| US-5021264-A | Whole or partial etherified 1,3-dialkyl-4,5-dihydroxy-imidazolidinone; shrink resistace | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | claimed |
| EP-0206588-B1 | COPOLYMER BINDER COMPOSITION AND FABRICS AND PAPERS TREATED THEREWITH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-09-12 | — | — | EP | claimed |
| EP-0330979-A2 | Aqueous composition for the treatment of textiles and method of making textile materials crease-proof | Pfersee Chemie GmbH (DE) | 1989-09-06 | — | — | EP | claimed |
| US-4847143-A | ADDITION POLYMER,GLYOXAL RESIN, METAL SALT CATALYST, AND SULFATE SURFACTANT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-07-11 | — | — | US | claimed |
| EP-0206588-A1 | Copolymer binder composition and fabrics and papers treated therewith | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-12-30 | — | — | EP | claimed |
| US-4619668-A | FORMALDEHYDE-FREE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1986-10-28 | — | — | US | claimed |
| US-4116625-A | TREATING WITH ACRYLIC COPOLYMER HAVING GLYCIDYL GROUP AND ALKYLENEOXIDE SIDE CHAIN; HEATING IN PRESENCE OF ACID CATALYST TO CLEAVE OXIRANE RING | DAIDO-MARUTA FINISHING CO., LTD. (JP) | 1978-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11298305-B2 | Compositions and methods for improving the appearance of the hair | KRT18, OAT, CKMT1A; CKMT1B | ADRA2C 4777/4885KMT2A 1443/4885MEN1 3783/4885 |
| US-11400042-B2 | Process for treating keratin fibres, comprising the application of a composition comprising urea or a derivative thereof, a polyol and an amino silicone | KRT18, CUTA, PUF60 | ADRA2C 4188/4885KMT2A 1413/4885MEN1 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.